Dr. Farrington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Cancer Treatment Centers of America
2520 Elisha Avenue
Zion, IL 60099Phone+1 800-322-9183
Education & Training
East Tennessee State University/Quillen College of MedicineFellowship, Medical Oncology, 2011 - 2013
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2008 - 2011
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2008
Certifications & Licensure
IA State License 2021 - 2026
IL State License 2013 - 2026
OH State License 2022 - 2026
IN State License 2022 - 2025
MI State License 2022 - 2025
OK State License 2022 - 2025
WI State License 2010 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsRituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centersTanya M. Wildes, Laura Catherine Farrington, Cecilia Yeung, Alexandra M. Harrington, Kelley V. Foyil
Therapeutic Advances in Hematology. 2014-02-01 - 1 citationsPalbociclib in Patients With Soft Tissue Sarcoma WithAmplifications: Results From the Targeted Agent and Profiling Utilization Registry Study.Scott Schuetze, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam
JCO Precision Oncology. 2024-07-01
Press Mentions
4 Things You Should Know About Breast CancerOctober 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
